Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.34 |
| ▸ | TK1 | P04183 | 8/20 | 0.33 |
| ▸ | TYMP | P19971 | 1/20 | 0.32 |
| ▸ | TK2 | O00142 | 4/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3696551 | 0.92 | RNASE1 (0.36) | RNASE1TK1TYMPTK2HPGD | |
| SCHEMBL4470358 | 0.84 | TK2 (0.34) | RNASE1TK1TYMPTK2HPGD | |
| SCHEMBL5668670 | 0.83 | RNASE1 (0.37) | RNASE1TK1TYMPTK2HPGD | |
| SCHEMBL6223881 | 0.79 | TK2 (0.33) | RNASE1TK1TYMPTK2 | |
| SCHEMBL3516066 | 0.77 | TK2 (0.32) | TK1TK2HPGD | |
| SCHEMBL4952762 | 0.76 | TK2 (0.39) | RNASE1TK1TYMPTK2HPGD | |
| SCHEMBL4949400 | 0.74 | TK2 (0.36) | RNASE1TK1TYMPTK2 | |
| SCHEMBL7195757 | 0.74 | TK1 (0.33) | TK1TK2 | |
| SCHEMBL313036 | 0.73 | TK1 (0.32) | TK1TK2HPGD | |
| SCHEMBL9396549 | 0.73 | RNASE1 (0.39) | RNASE1TK1TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1578927-A2 | ANTISENSE MODULATION OF NAV1.3 EXPRESSION | Pharmacia Corporation (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1575498-A2 | ANTISENSE MODULATION OF MICROSOMAL PROSTAGLANDIN E2 SYNTHASE EXPRESSION | Pharmacia Corporation (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1572713-A2 | ANTISENSE MODULATION OF ACYL-COA SYNTHETASE 1 EXPRESSION | Pharmacia Corporation (US) | 2005-09-14 | — | — | EP | disclosed |
| EP-1567538-A2 | ANTISENSE MODULATION OF GFAT EXPRESSION | Pharmacia Corporation (US) | 2005-08-31 | — | — | EP | disclosed |
| EP-1556509-A2 | ANTISENSE MODULATION OF VEGF CO-REGULATED CHEMOKINE-1 EXPRESSION | Pharmacia Corporation (US) | 2005-07-27 | — | — | EP | disclosed |
| EP-1549387-A1 | ANTISENSE MODULATION OF FARNESOID X RECEPTOR EXPRESSION | Pharmacia Corporation (US) | 2005-07-06 | — | — | EP | disclosed |
| EP-1543159-A2 | ANTISENSE MODULATION OF ENDOTHELIAL SPECIFIC MOLECULE 1 EXPRESSION | Pharmacia Corporation (US) | 2005-06-22 | — | — | EP | disclosed |
| EP-1539689-A2 | ANTISENSE MODULATION OF ENDOTHELIAL LIPASE EXPRESSION | Pharmacia Corporation (US) | 2005-06-15 | — | — | EP | disclosed |
| EP-1534728-A2 | ANTISENSE MODULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION | Pharmacia Corporation (US) | 2005-06-01 | — | — | EP | disclosed |
| EP-1520021-A2 | ANTISENSE MODULATION OF LRH1 EXPRESSION | Pharmacia Corporation (US) | 2005-04-06 | — | — | EP | disclosed |
| WO-2004030750-A1 | ANTISENSE MODULATION OF FARNESOID X RECEPTOR EXPRESSION | PHARMACIA CORPORATION (US) | 2004-04-15 | — | — | WO | disclosed |
| WO-2004028458-A2 | ANTISENSE MODULATION OF MICROSOMAL PROSTAGLANDIN E2 SYNTHASE EXPRESSION | PHARMACIA CORPORATION (US) | 2004-04-08 | — | — | WO | disclosed |
| WO-2004021978-A2 | ANTISENSE MODULATION OF ENDOTHELIAL SPECIFIC MOLECULE 1 EXPRESSION | PHARMACIA CORPORATION (US) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004016749-A2 | ANTISENSE MODULATION OF ACYL-COA SYNTHETASE 1 EXPRESSION | PHARMACIA CORPORATION (US) | 2004-02-26 | — | — | WO | disclosed |
| WO-2004016754-A2 | ANTISENSE MODULATION OF Nav1.3 EXPRESSION | PHARMACIA CORPORATION (US) | 2004-02-26 | — | — | WO | disclosed |
| WO-2004016224-A2 | ANTISENSE MODULATION OF VEGF CO-REGULATED CHEMOKINE-1 EXPRESSION | PHARMACIA CORPORATION (US) | 2004-02-26 | — | — | WO | disclosed |
| WO-2004009541-A2 | ANTISENSE MODULATION OF ENDOTHELIAL LIPASE EXPRESSION | PHARMACIA CORPORATION (US) | 2004-01-29 | — | — | WO | disclosed |
| WO-2004003201-A2 | ANTISENSE MODULATION OF LRH1 EXPRESSION | PHARMACIA CORPORATION (US) | 2004-01-08 | — | — | WO | disclosed |
| WO-2003099215-A2 | ANTISENSE MODULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION | PHARMACIA CORPORATION (US) | 2003-12-04 | — | — | WO | disclosed |
| US-20030176374-A1 | Oligonucleotide compositions and methods for the modulation of the expression of B7 protein | ISIS PHARMACEUTICALS, INC. | 2003-09-18 | — | — | US | disclosed |